Search Results
Dr. Arteaga on PI3K Pathway Inhibitors
The Emerging Role of PI3K Inhibition
Dr. Baselga Discusses Targeting PI3K in Breast Cancer
PI3K/Akt Pathway Inhibition for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Dr. Arteaga on Molecular Profiling in Triple-Negative Breast Cancer
PI3K inhibitors as a new weapon to combat Cancer.
Choosing Therapy for HR+ Metastatic Breast Cancer
The PI3K Pathway
PI3K Inhibitors for HR+ Metastatic Breast Cancer
2010 SABCS Interview with Carlos L. Arteaga, M.D.
Infinity PI3K-Delta,Gamma Inhibition
AACR Scientific Podcasts: Interview with Carlos L. Arteaga, M.D. at SABCS 2009
